生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Levetiracetam is an anticonvulsant with antihyperalgesic efficacy in inflammatory pain. It binds the synaptic vesicle protein SV2A (pIC50 = 5.7), presumably altering vesicle exocytosis. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01392768 | Epilepsy Part... 展开 >>ial Seizures 收起 << | Phase 3 | Completed | - | - |
NCT00413296 | Post-Traumatic Stress Disorder | Phase 2 Phase 3 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27705 收起 << |
NCT00826865 | Seizures | Not Applicable | Completed | - | United States, Arizona ... 展开 >> MDS Pharma Services Phoenix, Arizona, United States, 85044 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
5.88mL 1.18mL 0.59mL |
29.38mL 5.88mL 2.94mL |
58.75mL 11.75mL 5.88mL |
参考文献 |
---|